Mechanisms of TGF-β-induced cell cycle arrest

Mineral and Electrolyte Metabolism

Volumn 24, Issue 2-3, 1998, Pages 131-135

  Hocevar, Barbara A ^a   Howe, Philip H ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cyclin dependent kinase inhibitors; Cyclin dependent kinases (cdks); GI growth arrest; TGF

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW;

ANIMALS; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; G1 PHASE; GROWTH INHIBITORS; HUMANS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031884681     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057360     Document Type: Review

References (32)

1. Pardee AB: G1 events and regulation of cell proliferation. Science 1989;246:603-608.
2. Massague J: The transforming growth factor-β family. Ann Rev Cell Biol 1990;6:597-641.
3. cdc2 phosphorylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol 1991;11:1185-1194.
4. Alexandrow MG, Moses HL: Transforming growth factor β1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. Cancer Res 1995;55:3928-3932.
5. Thoreson GH, Refsnes M, Christofferson T: Inhibition of hepatocyte DNA synthesis by transforming growth factor β1 and cyclic AMP: Effect immediately before the G1/S border. Cancer Res 1992;52:3598-3603.
6. Kletsas D, Stathakos D, Sorrentino V, Philipson L: The growth-inhibitory block of TGF- is located close to the G1/S border in the cell cycle. Exp Cell Res 1995;217:477-483.
7. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995;81:323-330.
8. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J: Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 1990;62:175-185.
9. Sherr CJ: Gl phase progression: Cycling on cue. Cell 1994;79:551-555.
10. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-1163.
11. Geng Y, Weinberg RA: Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent protein kinases. Proc Natl Acad Sci USA 1993;90:10315-10319.
12. Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR, Reed SI: A novel inhibitor of cyclin-cdk activity detected in transforming growth factor β-arrested epithelial cells. Mol Cell Biol 1994;14:3683-3694.
13. Ewen ME, Sluss HK, Whitehouse LL, Livingston DM: TGFβ inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 1993;74:1009-1020.
14. Ewen ME, Oliver CJ, Sluss HK, Miller SJ, Peeper DS: p53-dependent repression of cdk4 translation in TGF-β-induced Gl cell-cycle arrest. Genes Dev 1995;9:204-217.
15. Feng X-H, Filvaroff EH, Derynck R: Transforming growth factor-β (TGF-β)-induced down-regulation of cyclin A expression requires a functional TGF-β receptor complex. J Biol Chem 1995;270:24237-24245.
16. Barlat I, Henglein B, Plet A, Lamb N, Fernandez A, McKenzie F, Pouyssegur J, Vie A, Blanchard JM: TGF-β1 and cAMP attenuate cyclin À gene transcription via a cAMP responsive element through independent pathways. Oncogene 1995;11:1309-1318.
17. Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-β. Science 1993;260:536-539.
18. Reddy KB, Hocevar BA, Howe PH: Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β1. J Cell Biochem 1994; 56:418-425.
19. Li C-Y, Suardet L, Little JB: Potential role of WAF1/Cip1/p21 as a mediator of TGF-β cytoinhibitory effect. J Biol Chem 1995;270: 4971-4974.
20. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang X-F: Transforming growth factor βinduces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995;92:5545-5549.
21. Kato J-Y, Matsuoka M, Polyak K, Massague J, Sherr CJ: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kipl) of cyclindependent kinase-activation. Cell 1994;79: 487-496.
22. kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
23. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995;9:639-649.
24. CIP1 cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995;9: 650-662.
25. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 1994;371:257-261.
26. pβ. Genes Dev 1995;9:1831-1845.
27. INK4B-cdk4 complexes, and inhibits cyclin Dl-cdk4 association in human mammary epithelial cells. Mol Cell Biol 1997;17:2458-2467.
28. Lukas J, Parry D, Aagard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J: Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 1995;375:503-506.
29. Koh J, Enders GH, Dynlacht BD, Harlow E: Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 1995; 375:506-510.
30. Herrera RE, Makela TP, Weinberg RA: TGFβ-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol Biol Cell 1996;7:1335-1342.
31. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 1996;85: 707-720.
32. Kip1. Oncogene 1996;13:2447-2457.